Abmel Xiques Castillo

Title: Abmel Xiques Castillo: Innovator in Radiopharmaceutical Compositions

Introduction

Abmel Xiques Castillo is a notable inventor based in Saint Laurent, CA. He has made significant contributions to the field of radiopharmaceuticals, particularly with his innovative compositions that enhance the diagnosis and treatment of various diseases. His work is characterized by a commitment to improving the safety and efficacy of medical treatments.

Latest Patents

Abmel Xiques Castillo holds a patent for "Radiopharmaceutical compositions of radioactive halogenated benzylguanidine." This patent focuses on compositions that include radioactive halogenated benzylguanidine, such as radioiodinated MIBG, or its pharmaceutically acceptable salts, hydrates, or solvates. A key feature of this composition is its high radiochemical purity, which is maintained at over 97% for at least four days. Importantly, these compositions are devoid of parabens, which are known carcinogens commonly found in existing radioactive MIBG formulations. The patent also outlines processes for preparing these innovative compositions.

Career Highlights

Abmel Xiques Castillo is associated with Jubilant Draximage Inc., where he applies his expertise in radiopharmaceuticals. His work at the company has positioned him as a key player in the development of safer and more effective medical treatments. His dedication to research and innovation has led to advancements that benefit both healthcare professionals and patients.

Collaborations

Abmel collaborates with Robert William Riddoch, contributing to the advancement of radiopharmaceutical technologies. Their partnership exemplifies the importance of teamwork in the field of medical innovation.

Conclusion

Abmel Xiques Castillo's contributions to radiopharmaceutical compositions demonstrate his commitment to enhancing medical treatments. His innovative work not only improves patient safety but also paves the way for future advancements in the field.